Navigation Links
Ansell Extends Success of AMT Antimicrobial Technology for Surgical Gloves With Introduction in Europe
Date:11/4/2011

BRUSSELS, REDBANK, New Jersey and MELBOURNE, Australia, November 4, 2011 /PRNewswire/ --

Global leader in healthcare protection and safety solutions lands CE Mark for GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology.

One year after its introduction in Australia, Ansell today announced it is kicking off a European launch program of their new GAMMEX® Powder-Free glove with AMT Antimicrobial Technology.

The GAMMEX® Powder-Free glove with AMT Antimicrobial Technology is the first surgical glove which incorporates a proprietary antimicrobial coating to provide an additional level of protection to surgical staff against viruses and bacteria, in the event of a breach during surgery.  

Ever since its introduction last year in Australia, this unique Ansell innovation received overall industry acclaim and is being considered a significant technical breakthrough in terms of bringing about a change from passive protection to active protection.

The gloves, made of NRL, provide the same feel, sensitivity, flexibility and dexterity as conventional gloves when manipulating and handling instruments. The main difference is the active antimicrobial layer which contains chlorhexidine gluconate (CHG). This technology can provide ongoing antiviral and antibacterial protection against HIV, hepatitis C and infectious bacteria.

"Improving healthcare systems around the world and an increasing awareness by healthcare workers that gloves offer an effective protection against contamination from bacteria and viruses have been a key driver for the rapid expansion of the medical gloves industry," says Magnus Nicolin, CEO of Ansell Limited.  

"This unique and proprietary AMT Antimicrobial Technology reduces surgical staff risks of exposure to blood-borne pathogens through a higher level of protection," he continues.  "Just as the introduction of the first surgeon gloves significantly decreased surgical site infections, Ansell has great expectations that this glove will take patient protection to another level.  We will now be focusing our research efforts on clinically quantifying the potential that this surgical glove innovation has on reducing the number of Hospital Acquired Infections (HAI's) and any costs associated," he concludes.

First launched in Australia and Europe, Ansell's AMT Antimicrobial Technology will progressively be rolled out in all Ansell markets.
* In clinical and laboratory tests, GAMMEX® Powder-Free with AMT killed at least 99% of invading HIV and HCV (hepatitis C) surrogate pathogens, the two main viruses that concern surgeons. In addition, clinical testing has shown that the gloves kill over 99.7% of eight common infectious bacteria (gram-positive, gram-negative and drug-resistant bacteria) and kill over 99.99% of staphylococcus aureus.

GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology are not proven to protect against blood-borne infections where the skin is broken, cut or punctured. GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology contain natural rubber latex, which may cause allergic reactions.

Australia Patent No. 703926 and New Zealand Patent No. 556353. AU and worldwide patents pending.

Ansell, ® and ™ are trademarks owned by Ansell Limited or one of its affiliates.  © 2011 Ansell Limited. All rights reserved.


'/>"/>
SOURCE Ansell Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ansell Healthcare Receives CE Mark for GAMMEX® Powder-Free Gloves With AMT Antimicrobial Technology
2. Ansell Limited Acquires Sandel Medical Industries LLC, an Innovator in Surgical Safety Solutions
3. Leading Online Patient Education Resource Extends Outreach to Include Aesthetic Physician Community
4. Accuray Extends Industry-Leading Customer Service Program to TomoTherapy Systems
5. St. Vincents Medical Center Extends Licensing Agreement With Streamline Health and Migrates to SaaS Model
6. Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia
7. Verathon Extends Range of GlideScope Video Laryngoscope With New Single Use - GVL 2.5 Stat for Small Children
8. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
9. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
10. InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems
11. Nephros Extends Rights Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
(Date:9/6/2017)... --  PDI , a leader in infection prevention products ... session focused on the role of chlorhexidine gluconate (CHG) ... 2017 Annual Scientific Meeting of the Association for Vascular ... Phoenix Convention Center in ... also feature PDI,s Prevantics® Device Swab as ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... , ... “Letters From Home”: a moving compilation of letters that remind ... “Letters From Home” is the creation of published author, John Allred, a passionate leader ... Savelle Ministries International, who has traveled and ministered on four continents. , “It is ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... other tick-borne diseases through research, education and awareness, today announced the appointment of ... immunologist and microbiologist, Dr. Sellati has more than 20 years of research experience ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices ... – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in ... afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at ...
(Date:9/21/2017)... Church, VA (PRWEB) , ... September 21, 2017 ... ... Policy , **An FDAnews Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the competitive ... edge they can get while staying in compliance with FDA rules. , The ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... Bill Howe ... to its customers, and give back to the community. For over 37 years, they ... most successful companies serving plumbing in San Diego. They were chosen as ...
Breaking Medicine News(10 mins):